Clinical trial
Phase 1 Study of Zoledronic Acid in Sickle Cell Disease
NCT00639392 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 1 Study of Zoledronic Acid in Sickle Cell Disease
- Lead sponsor
- Virginia Commonwealth University
- Phase
- Phase 1/2
- Overall status
- Withdrawn
- Start date
- June 30, 2007
- Completion date
- May 31, 2008
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
sickle cell disease